Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML

Clinical trial NCT00123474 · COMPLETED

Trial details

NCT number: NCT00123474
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Myeloid Leukemia, Chronic, Chronic-Phase

Start date: 2005-07-01
Primary completion: 2006-09-01
Enrollment: 724

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.